Division of Alcohol and Drug Abuse, McLean Hospital, Belmont, MA, USA.
Psychiatry Res. 2011 Dec 30;190(2-3):253-8. doi: 10.1016/j.psychres.2011.05.042. Epub 2011 Jun 22.
We examined the impact of substance use disorder (SUD) history among patients with bipolar I disorder (BD) in regards to medication-taking behaviors and attitudes. Interviews were conducted with inpatients hospitalized for BD, which included diagnostic instruments and measures of attitudes concerning psychiatric medications. We compared patients with BD and no history of SUD (BD-NH), BD and past history of SUD (BD-PH), and BD and current SUD (BD-C). The primary outcome variable was a standardized medication adherence ratio (SMAR) of [medication taken]/[medication prescribed]. Fifty-four patients with a BD diagnosis participated, which included BD-NH (n=26), BD-PH (n=19), and BD-C (n=9). The SMAR was significantly different among the three groups; post-hoc analyses revealed the SMAR was significantly lower among BD-C (M=0.70) compared to BD-NH (M=0.90) and BD-PH (M=0.97) patients. This finding remained significant after controlling for numerous patient characteristics. Attitudes regarding medications, measured by the Drug Attitude Inventory (DAI), were positive among a significantly higher percentage of BD-PH (89.47%) and BD-NH (65.38%) compared to BD-C (44.44%) patients. In conclusion, patients with BD-C demonstrated poor medication adherence and attitudes concerning medication management. Helping patients with BD achieve remission from SUD may lead to a more successful course of BD pharmacotherapy.
我们研究了物质使用障碍(SUD)病史对双相情感障碍(BD)患者药物治疗行为和态度的影响。对因 BD 住院的患者进行了访谈,包括诊断工具和对精神药物的态度的测量。我们比较了无 SUD 病史的 BD 患者(BD-NH)、有 SUD 病史的 BD 患者(BD-PH)和有当前 SUD 的 BD 患者(BD-C)。主要结局变量是标准化药物依从性比值(SMAR)[用药量/处方用药量]。共有 54 名 BD 诊断患者参与,包括 BD-NH(n=26)、BD-PH(n=19)和 BD-C(n=9)。三组间的 SMAR 存在显著差异;事后分析显示,BD-C 组(M=0.70)的 SMAR 显著低于 BD-NH 组(M=0.90)和 BD-PH 组(M=0.97)。在控制了许多患者特征后,这一发现仍然具有统计学意义。通过药物态度量表(DAI)测量的药物态度,BD-PH(89.47%)和 BD-NH(65.38%)患者显著高于 BD-C(44.44%)患者。总之,BD-C 患者表现出较差的药物依从性和对药物管理的态度。帮助 BD 患者从 SUD 中康复可能会导致 BD 药物治疗更成功。